Allergan rose$. 45 or. 2 percent, to $212.63. Baxter International Inc. rose$. 41 or. 6 percent, to $74.48. Boston Scientific Corp. fell$. 11 or. 8 percent, to $13.15.» Read More
With stocks shrugging off the wall of worry in the first quarter, the second quarter could prove to be a less rewarding time for those long equity markets as central banks begin to tighten policy via rate hikes or withdrawing extraordinary measures.
The "Mad Money" host shares a few interesting spec plays in the health care space.